Home Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-α levels in patients with ischemic heart disease
Article
Licensed
Unlicensed Requires Authentication

Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-α levels in patients with ischemic heart disease

  • Vidosava B. Djordjevic , Ivana Stojanovic , Vladan Cosic , Lilika Zvezdanovic , Marina Deljanin-Ilic , Senada Dimic , Braca Kundalic , Tatjana Cvetkovic and Tatjana Jevtovic-Stoimenov
Published/Copyright: June 20, 2008

Abstract

Background: Atherosclerosis, a chronic inflammatory disease, underlies the pathogenesis of coronary artery disease. The present study assessed the diagnostic possibilities of inflammatory biomarkers, serum neopterin, nitrite/nitrate (NO2/NO3), inducible nitric oxide synthase (iNOS) and tumor necrosis factor-α (TNF-α), and their correlation with risk factors in patients with acute coronary syndromes and stable angina pectoris.

Methods: We studied 44 patients with chronic stable angina pectoris, 46 with unstable angina, 55 with acute ST-elevation myocardial infarction and 39 age-matched healthy volunteers (control group). Serum neopterin, iNOS and TNF-α were determined with commercially available enzyme linked immunosorbent assay methods and NO2/NO3 by the modified cadmium-reduction method.

Results: Mean serum neopterin levels were significantly higher in patients with unstable and stable angina pectoris in comparison to control subjects (p<0.01 and p<0.05, respectively). Serum NO2/NO3 values were significantly elevated (p<0.01) only in patients with unstable angina. ST-elevation myocardial infarction patients with cardiac death during follow-up showed significantly lower baseline neopterin values (p<0.001), and higher NO2/NO3 levels (p<0.05) in comparison to those without adverse events. Significantly higher NO2/NO3 values (p<0.05) were also found in patients who had myocardial reinfarction. Serum iNOS and TNF-α in all patient groups were within control ranges. A strong correlation was found between neopterin and both smoking (p<0.01) and triglycerides (p<0.05) in unstable angina patients. In stable angina patients, neopterin, iNOS and TNF-α significantly correlated with hypertension (p<0.01) and triglycerides (p<0.05). A significant difference in neopterin concentration was found between smokers and non-smokers (p<0.05).

Conclusions: The results of this study suggest that in stable angina patients, if studied over time, serum neopterin or NO2/NO3 levels may indicate future plaque instability. In ST-elevation myocardial infarction patients, neopterin and/or NO2/NO3 levels may identify patients at long-term risk of death or recurrent acute coronary events after myocardial infarction.

Clin Chem Lab Med 2008;46:1149–55.


Corresponding author: Prof. Vidosava B. Djordjević, PhD, Institute of Biochemistry, Faculty of Medicine, Bul. dr Zorana Djindjića 81, 18000 Niš, Serbia Phone: +381-18-535-666, Fax: +381-18-238-770,

Received: 2007-12-10
Accepted: 2008-3-31
Published Online: 2008-06-20
Published in Print: 2008-08-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Insulin-like growth factor-I and complications of prematurity: a focus on bronchopulmonary dysplasia
  3. Minireview
  4. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management
  5. Genetics and Molecular Diagnostics
  6. Proteomic pattern of plasma in off-pump coronary artery bypass surgery
  7. Association of CHRNA2 polymorphisms with overweight/obesity and clinical characteristics in a Korean population
  8. Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers
  9. Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction in Tunisian patients
  10. The influence of smoking and homocysteine on subclinical atherosclerosis is modified by the connexin37 C1019T polymorphism – The Cardiovascular Risk in Young Finns Study
  11. Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP
  12. An improved quality control for bisulfite-PCR-based DNA methylation analysis: cycle threshold value
  13. General Clinical Chemistry and Laboratory Medicine
  14. Can E-cadherin and CD34 be used as indicators of prognosis for hepatocellular carcinoma patients?
  15. Determination of serum creatinine by Jaffe method and how to calibrate to eliminate matrix interference problems
  16. Calcium oxalate stone formation risk – a case of disturbed relative concentrations of urinary components
  17. Half-lives of albumin and cholinesterase in critically ill patients
  18. Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood
  19. Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-α levels in patients with ischemic heart disease
  20. Estimation of serum M-protein concentration from polyclonal immunoglobulins: an alternative to serum protein electrophoresis and standard immunochemical procedures
  21. Are serum lipids measured on stroke admission prognostic?
  22. Reference Values and Biological Variations
  23. Pre-analytical variation of some haematological quantities
  24. Long-term stability of endogenous B-type natriuretic peptide after storage at –20°C or –80°C
  25. Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations?
  26. Non-homogeneous separation of triglycerides, γ-glutamyltransferase, C-reactive protein and lactate dehydrogenase after centrifugation of lithium-heparin tubes
  27. Validation and Outcome Studies
  28. Computer-assisted detection of monoclonal components: results from the multicenter study for the evaluation of CASPER (Computer Assisted Serum Protein Electrophoresis Recognizer) algorithm
  29. Quality indicators and specifications for strategic and support processes in laboratory medicine
  30. Evaluation of the DCA Vantage analyzer for HbA1c assay
  31. Letters to the Editor
  32. Optimization of imprecision and cost saving on hemoglobin A1c controls through aliquot freezing
  33. Estimation of glomerular filtration rate by the modification of diet in renal disease (MDRD) equation in patients with sickle cell disease
  34. Abstracts
  35. Swiss MedLab 2008: International Congress, September 16–19, 2008, Montreux, Switzerland
  36. 4th Biologie Prospective Santorini Conference, September 21–23, 2008, Santorini, Greece
Downloaded on 13.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.213/html?lang=en
Scroll to top button